Systemic administration of amylin increases bone mass, linear growth, and adiposity in adult male mice

American Journal of Physiology - Endocrinology and Metabolism

Volumn 275, Issue 4 38-4, 1998, Pages

  Cornish, Jillian ^a   Callon, Karen E ^a   King, Alan R ^b   Cooper, Garth J S ^a,c   Reid, Ian R ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b MIDDLEMORE HOSPITAL   (New Zealand)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Bone metabolism; Growth plate; Obesity; Osteoblasts; Osteoporosis

Indexed keywords

AMYLIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY FAT; BONE GROWTH; BONE MASS; BONE METABOLISM; DRUG EFFECT; HORMONE ACTION; MALE; MOUSE; NONHUMAN; OSTEOPOROSIS; PRIORITY JOURNAL;

EID: 0031741159     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.1998.275.4.e694     Document Type: Article

References (25)

1. Alam, A. S., B. S. Moonga, P. J. Bevis, C. L. Huang, and M. Zaidi. Amylin inhibits bone resorption by a direct effect on the motility of rat osteoclasts. Exp. Physiol. 78: 183-196, 1993.
2. Ballica, R., K. Valentjin, A. Khachatryan, S. Guerder, S. Kapadia, I. Millet, N. Troiana, C. Gundberg, T. Crawford, H. Z. Ke, J. P. Gilligan, R. Flavell, and A. Vignery. Targeted expression of calcitonin gene-related peptide to osteoblasts in transgenic mice increases bone density (Abstract). J. Bone Miner. Res. 12, Suppl. 1: S117, 1997.
3. Blakely, P., D. A. Vaughn, and D. D. Fanestil. Amylin, calcitonin gene-related peptide, and adrenomedullin: effects on thiazide receptor and calcium. Am. J. Physiol. 272 (Renal Fluid Electrolyte Physiol. 41): F410-F415, 1997.
4. Burns, M. D., and T. Kawase. Calcitonin gene-related peptide, amylin, or parathyroid hormone stimulate (in vitro) biomineralization (Abstract). J. Bone Miner. Res. 12, Suppl. 1: S324, 1997.
5. Cooper, G. J. S., A. J. Day, A. C. Willis, A. N. Roberts, K. B. M. Reid, and B. Leighton. Amylin and the amylin gene: structure, function and relationship to islet amyloid and to diabetes mellitus. Biochim. Biophys. Acta 1014: 247-258, 1989.
6. Cooper, G. J. S., B. Leighton, G. D. Dimitriadis, M. Parry-Billings, J. M. Kowalchuk, B. Rowland, J. B. Rothbard, A. C. Willis, and K. B. M. Reid. Amylin found in amyloid deposits in human type 2 diabetes mellitus may be a hormone that regulates glycogen metabolism in skeletal muscle. Proc. Natl. Acad. Sci. USA 85: 7763-7766, 1988.
7. Cornish, J., K. Callon, G. J. S. Cooper, and I. R. Reid. The effect of amylin in neonatal mouse calvaria (Abstract). Bone Miner. 25, Suppl. 1: S41, 1994.
8. Cornish, J., K. E. Callon, G. J. S. Cooper, and I. R. Reid. Amylin stimulates osteoblast proliferation and increases mineralized bone volume in adult mice. Biochem. Biophys. Res. Commun. 207: 133-139, 1995.
9. Cornish, J., K. E. Callon, D. H. Coy, N. Y. Jiang, L. Q. Xiao, G. J. S. Cooper, and I. R. Reid. Adrenomedullin is a potent stimulator of osteoblastic activity in vitro and in vivo. Am. J. Physiol. 273 (Endocrinol. Metab. 36): E1113-E1120, 1997.
10. Cornish, J., K. E. Callon, C. Q.-X. Lin, C. L. Xiao, T. B. Mulvey, D. H. Coy, G. J. S. Cooper, and I. R. Reid. Dissociation of the effects of amylin on osteoblast proliferation and bone resorption. Am. J. Physiol. 274 (Endocrinol. Metab. 37): E827-E833, 1998.
11. Davies, K. M., R. R. Recker, M. R. Stegman, and R. P. Heaney. Tallness versus shrinkage: do women shrink with age or grow taller with recent birth date? J. Bone Miner. Res. 6: 1115-1120, 1991.
12. Leighton, B., and G. J. S. Cooper. Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in vivo. Nature 335: 632-635, 1988.
13. Meredith, H. V. Findings from Asia, Australia, Europe, and North America on secular changes in mean height of children, youths, and young adults. Am. J. Phys. Anthropol. 44: 315-326, 1976.
14. Muscaritoli, M., J. R. Gleason, M. M. Meguid, and H. C. Lukaski. Densitometry-based equations for estimating body composition in Fischer rats. Nutrition 9: 439-445, 1993.
15. Parfitt, A. M., C. H. E. Mathews, A. R. Villanueva, M. Kleerekoper, B. Frame, and D. S. Rao. Relationships between surface, volume, and thickness of iliac trabecular bone in aging and osteoporosis. J. Clin. Invest. 72: 1396-1409, 1983.
16. Pietschmann, P., K. H. Farsoudi, O. Hoffmann, K. Klaushofer, H. Horandner, and M. Peterlik. Inhibitory effect of amylin on basal and parathyroid hormone-stimulated bone resorption in cultured neonatal mouse calvaria. Bone 14: 167-172, 1993.
17. Reid, I. R., R. Ames, M. C. Evans, S. Sharpe, G. Gamble, J. T. France, T. M. T. Lim, and T. F. Cundy. Determinants of total body and regional bone mineral density in normal postmenopausal women - a key role for fat mass. J. Clin. Endocrinol. Metab. 75: 45-51, 1992.
18. Reid, I. R., and J. Cornish. Amylin and CGRP. In: Principles of Bone Biology (1st ed.), edited by J. P. Bilezekian, L. G. Raisz, and G. A. Rodan. San Diego, CA: Academic, 1996, p. 495-505.
19. Romero, D. F., H. P. Bryer, B. Rucinski, J. A. Isserow, F. J. Buchinsky, M. Cvetkovic, C. C. Liu, and S. Epstein. Amylin increases bone volume but cannot ameliorate diabetic osteopenia. Calcif. Tissue Int. 56: 54-61, 1995.
20. Shih, C., and G. W. Bernard. Calcitonin gene related peptide enhances bone colony development in vitro. Clin. Orthop. 334: 335-344, 1997.
21. Tamura, T., C. Miyaura, I. Owan, and T. Suda. Mechanism of action of amylin in bone. J. Cell. Physiol. 153: 6-14, 1992.
22. Valentijn, K., A. P. Gutow, N. Troiano, C. Gundberg, J. P. Gilligan, and A. Vignery. Effects of calcitonin gene-related peptide on bone turnover in ovariectomized rats. Bone 21: 269-274, 1997.
23. Villa, I., A. Rubinacci, F. Ravasi, A. F. Ferrara, and F. Guidobono. Effects of amylin on human osteoblast-like cells. Peptides 18: 537-540, 1997.
24. Young, A. A., W. Vine, B. R. Gedulin, R. Pittner, S. Janes, L. S. L. Gaeta, A. Percy, C. X. Moore, J. E. Koda, T. J. Rink, and K. Beaumont. Preclinical pharmacology of pramlintide in the rat - comparisons with human and rat amylin. Drug Dev. Res. 37: 231-248, 1996.
25. Young, A. A., M.-W. Wang, and G. J. S. Cooper. Amylin injection causes elevated plasma lactate and glucose in the rat. FEBS Lett. 291: 101-104, 1991.